Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Are you Dr. Ikoma?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Naruhiko Ikoma, MD is a general surgeon in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and Arizona.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2015 - 2018
University of Texas Health Science Center at HoustonResidency, Surgery, 2011 - 2015
Keio Gujuku University School of MedicineClass of 2007
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Enhanced recovery after laparoscopic distal gastrectomy using articulating laparoscopic instruments in older adults with gastric cancer: a retrospective analysis of pr...Seohee Choi, Takahiro Kinoshita, Kazutaka Obama, Katsunobu Sakurai, Naoshi Kubo
Annals of Surgical Treatment and Research. 2025-02-01 - 1 citationsPhase 1 Trial of Total Neoadjuvant Therapy With Short-Course Chemoradiotherapy Followed by Chemotherapy for Patients With Potentially Resectable Gastric Cancer.Brian Badgwell, Naruhiko Ikoma, Mariela Blum Murphy, Jenny Li, Xuemei Wang
International Journal of Radiation Oncology, Biology, Physics. 2025-02-01 - Phase 1 trial of intraperitoneal paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology.Brian Badgwell, Naruhiko Ikoma, Mariela Blum, Xuemei Wang, Jeannelyn Estrella
Cancer. 2025-01-01
Authored Content
- Response and Survival Associated with First-Line FOLFIRINOX vs GemcitabineJuly 2020
- Response and Survival Associated with First-Line FOLFIRINOX vs GemcitabineJuly 2020
Press Mentions
Six-Time Cancer Survivor: How My Diagnoses Led Me to MD AndersonApril 7th, 2023- Robots Are Taking over Your Surgery (And You Should Be Excited)September 27th, 2023
Grant Support
- Receptor-Targeted Fluorescence-Guided Surgery in Pancreatic Neuroendocrine TumorsUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2022–2028
